Cargene Biopharma, a biopharmaceutical company developing oligonucleotide therapeutics for liver and ophthalmic disorders, has appointed Kathy He as CEO and member of the board. He, a seasoned biopharmaceutical industry executive,…
Cargene Biopharma, a biopharmaceutical company developing oligonucleotide therapeutics for liver and ophthalmic disorders, has appointed Kathy He as CEO and member of the board. He, a seasoned biopharmaceutical industry executive,…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


